*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Please join us learn more about the work of this vital Georgia Tech resource for biomedical research.
Using proven high-quality processes, the Global Center for Medical Innovation’s staff serves Fortune 500, start-up, academic and government-funded innovators. GCMI works in over 11 therapeutic areas and a wide array of medical products (Class I, II and III) including drugs and biologics. GCMI is a fee-for-service provider with in-house expertise for successfully executing the medical product value-chain including lifecycle advisory, design and development, preclinical testing and bioskills training. Utilizing in-house resources, local core-lab resources and third-party service providers located around the world, GCMI works every day to commercialize innovative medical products that improve quality-based outcomes and delivery of healthcare for patients.
Please join Sherry Farrugia (CEO of GCMI), Saylan Lukas (Interim Director, Research and Development Engineering), and Evan Goldberg (Director, Scientific Affairs) as they present GCMI’s capabilities and discuss specifics as to how GT faculty work with GCMI to develop medical technologies. There will be ample time for Q&A and robust discussion.
Click here to join the meeting.
--
GCMI, and its wholly-owned subsidiary T3 Labs, is a non-profit 501(c)(3) and affiliate of the Georgia Institute of Technology, a member of the University System of Georgia.
